Skip to main content

Advertisement

SpringerLink
Log in

Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Background and aim

Mac-2-binding protein glycosylation isomer (M2BPGi) is a novel serum diagnostic marker for liver fibrosis in various liver diseases. We aimed to evaluate its role in assessment of liver fibrosis in chronic hepatitis B infection (CHB) with reference to liver stiffness measurement (LSM).

Methods

CHB patients with LSM by transient elastography technology and retrievable serum samples were recruited. Ten-year re-assessments of LSM and M2BPGi were repeated in a patient subgroup.

Results

240 CHB patients (M:F = 116:124; median age 47.5 years) were recruited. The median M2BPGi values for F0/F1/F2, F3 and F4 progressively increased with more advanced stages of liver fibrosis: 0.39, 0.46 and 0.82 COI, respectively (p < 0.01). M2BPGi levels correlated well with liver stiffness (r = 0.611), FIB-4 (r = 0.616), and strongly with APRI (r = 0.825) (all p < 0.001). Using cut-off values of 0.605 and 0.615 COI, the AUROCs were 0.754 and 0.799 for ≥ F3 and F4, respectively. M2BPGi identified one-quarter patients at risk of advanced fibrosis/cirrhosis otherwise classified into ‘grey area’ by LSM. In 86 patients with reassessment LSM, 21 (24.4%) showed significant fibrosis regression with corresponding decline in median M2BPGi level (− 0.11 COI) compared with the increase of +0.03 COI in patients without significant fibrosis regression (p = 0.011). Male gender, older age, use of potent antiviral therapy and change in serum M2BPGi were independently associated with significant fibrosis regression.

Conclusions

Serum M2BPGi can risk-stratify CHB patients whose liver stiffness fell into the ‘grey area’. Significant fibrosis regression occurring in one-quarter patients was reflected by a reduction in M2BPGi levels at 10-year interval.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. World Health Organization Fact Sheet on Hepatitis B [http://www.who.int/mediacentre/factsheets/fs204/en/]

  2. European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L: EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67:370–398

    Article  Google Scholar 

  3. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97(10):2614–2618

    Article  PubMed  Google Scholar 

  4. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343–350

    Article  PubMed  Google Scholar 

  5. Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med 2013;158(11):807–820

    Article  PubMed  Google Scholar 

  6. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134(4):960–974

    Article  PubMed  Google Scholar 

  7. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Tatsumi A, et al. Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn Reson Imaging 2015;33(1):26–30

    Article  PubMed  Google Scholar 

  8. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007;7:40

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. European Association for Study of Liver. Asociacion Latinoamericana para el Estudio del Higado Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63(1):237–264

    Article  Google Scholar 

  10. Kuno A, Ikehara Y, Tanaka Y, Ito K, Matsuda A, Sekiya S, et al. A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep 2013;3:1065

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. Nishikawa H, Takata R, Enomoto H, Yoh K, Kishino K, Shimono Y, et al. Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2-binding protein in chronic hepatitis C. Hepatol Res 2017;47(3):E74–E84

    Article  PubMed  CAS  Google Scholar 

  12. Abe M, Miyake T, Kuno A, Imai Y, Sawai Y, Hino K, et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol 2015;50(7):776–784

    Article  PubMed  CAS  Google Scholar 

  13. Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, et al. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol 2015;110(6):857–864

    Article  PubMed  CAS  Google Scholar 

  14. Nishikawa H, Enomoto H, Iwata Y, Hasegawa K, Nakano C, Takata R, et al. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis. Hepatol Res 2016;46(7):613–621

    Article  PubMed  CAS  Google Scholar 

  15. Yamada N, Sanada Y, Tashiro M, Hirata Y, Okada N, Ihara Y. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. J Gastroenterol 2017;52(2):245–252

    Article  PubMed  CAS  Google Scholar 

  16. Zou X, Zhu MY, Yu DM, Li W, Zhang DH, Lu FJ, et al. Serum WFA + -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection. Liver Int 2017;37(1):35–44

    Article  PubMed  CAS  Google Scholar 

  17. Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, et al. Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients. Hepatol Res 2016;46(11):1065–1073

    Article  PubMed  CAS  Google Scholar 

  18. Cheung KS, Seto WK, Wong DK, Mak LY, Lai CL, Yuen MF. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment. Oncotarget 2017;8:47507–17

    PubMed  PubMed Central  Google Scholar 

  19. Fung J, Lai CL, Wong DK, Seto WK, Hung I, Yuen MF. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. J Viral Hepatitis 2011;18(7):e200–e205

    Article  CAS  Google Scholar 

  20. Fung J, Lai CL, Cheng C, Wu R, Wong DK, Yuen MF. Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol 2011;106(3):492–496

    Article  PubMed  CAS  Google Scholar 

  21. Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010;51(3):828–835

    PubMed  Google Scholar 

  22. Wong GL, Wong VW, Chim AM, Yiu KK, Chu SH, Li MK. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 2011;26(2):300–305

    Article  PubMed  Google Scholar 

  23. Mak LY, Wong DK, Cheung KS, Seto WK, Lai CL, Yuen MF. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection. Clin Transl Gastroenterol 2018;9(6):163

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  24. Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination. J Gastroenterol Hepatol 2013;28(12):1842–1848

    Article  PubMed  CAS  Google Scholar 

  25. Enomoto M, Mori M, Ogawa T, Fujii H, Kobayashi S, Iwai S, et al. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: regression of liver stiffness during entecavir therapy. Hepatol Res 2010;40(9):853–861

    Article  PubMed  CAS  Google Scholar 

  26. Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, Kitahara S, et al. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol 2011;46(11):1324–13334

    Article  PubMed  CAS  Google Scholar 

  27. Schiff ER, Lee SS, Chao YC, Kew Yoon S, Bessone F, Wu SS, et al. Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin Gastroenterol Hepatol 2011;9(3):274–276

    Article  PubMed  CAS  Google Scholar 

  28. Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 2013;381(9865):468–475

    Article  PubMed  CAS  Google Scholar 

  29. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001;21(3):351–372

    Article  PubMed  CAS  Google Scholar 

  30. Morio K, Imamura M, Daijo K, Teraoka Y, Honda F, Nakamura Y, et al. Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury. J Gastroenterol 2017;52(12):1252–1257

    Article  PubMed  CAS  Google Scholar 

  31. Kono M, Nakamura Y, Oyama Y, Mori K, Hozumi H, Karayama M, et al. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis. Respir Med 2016;115:46–52

    Article  PubMed  Google Scholar 

  32. Okada A, Kanzaki H, Hamatani Y, Takashio S, Takahama H, Amaki M, et al. Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study. Heart Vessels 2017;15:16–17 https://doi.org/10.1007/s00380-00017-01071-00387 [Epub ahead of print]

    Article  Google Scholar 

  33. Xie H, Zhang Z, Chen L, Zhang P, Cui Y, Liu H, et al. Elevated plasma levels of Mac-2 binding protein predict poor cardiovascular outcomes in patients with acute coronary syndrome. Coron Artery Dis 2017;28(8):683–689

    Article  PubMed  Google Scholar 

  34. Waragai Y, Suzuki R, Takagi T, Sugimoto M, Asama H, Watanabe K, et al. Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinoma. Pancreatology 2016;16(6):1044–1050

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

We would like to thank Sysmex Corp. for supporting the measurement of M2BPGi and Health-Tech for performing the measurement.

Author information

Authors and Affiliations

  1. Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road 102, Hong Kong, China

    Lung-Yi Mak, Danny Ka-Ho Wong, Wai-Kay Seto, Ka-Shing Cheung, James Fung, Ching-Lung Lai & Man-Fung Yuen

  2. State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China

    Danny Ka-Ho Wong, Wai-Kay Seto, James Fung, Ching-Lung Lai & Man-Fung Yuen

  3. Institute of Infectious Disease, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China

    Qin Ning

Authors
  1. Lung-Yi Mak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Danny Ka-Ho Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wai-Kay Seto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qin Ning
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ka-Shing Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. James Fung
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ching-Lung Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Man-Fung Yuen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LYM was involved in drafting the manuscript. DKHW was involved in performing laboratory tests and collecting the data. WKS, QN and JF were involved in interpretation of the data and critical revision of the manuscript. KSC was involved in analysis of data. CLL was involved in critical revision of the manuscript. MFY was involved in study concept and design, analysis and interpretation of data, critical revision of manuscript, and overall study supervision. All authors have approved the final draft submitted.

Corresponding authors

Correspondence to Lung-Yi Mak, Wai-Kay Seto or Man-Fung Yuen.

Ethics declarations

Conflict of interest

No potential conflicts of interest to disclose for the authors Lung-Yi Mak, Danny Ka-Ho Wong, Wai-Kay Seto, Qin Ning, Ka-Shing Cheung, James Fung, Ching-Lung Lai, and Man-Fung Yuen.

Ethical approval

This study was approved by the Institutional Review Board/Ethics Committee of the University of Hong Kong and the Hong Kong West Cluster of Hospital Authority.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 6557 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mak, LY., Wong, D.KH., Seto, WK. et al. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection. Hepatol Int 13, 148–156 (2019). https://doi.org/10.1007/s12072-019-09928-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-019-09928-5

Keywords

Search

Navigation